spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  respiratory disease 

 HSMN NewsFeed - 21 Jul 2026
Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2026
Theravance Biopharma Enters into Definite Agreement to be Acquired by Zymeworks for $17.00 Per Share in Cash Plus a Contingent Value Right
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Feb 2026
Synchrony Medical Secures $5M Funding to Fuel Commercial Expansion of its At-Home Airway Clearance Device for Chronic Respiratory Disease
Devices Venture Capital
 HSMN NewsFeed - 23 Dec 2024
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
Biopharmaceuticals
 HSMN NewsFeed - 3 Nov 2022
Grifols Receives FDA Clearance for Alphaid(TM) At Home, the First Free Service for U.S. Consumers to Determine Their Risk for Alpha-1
Diagnostics FDA
 HSMN NewsFeed - 2 Aug 2022
Eleven Therapeutics Announces $22 Million in Seed Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Apr 2022
OncoSec Appoints Dr. Robert Arch as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Mar 2022
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of the BRIGHT Phase III Clinical Trial Evaluating PRX-102 for the Treatment of Fabry Disease
Biopharmaceuticals
 HSMN NewsFeed - 24 Feb 2022
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce the Submission of a Marketing Authorization Application to the European Medicines Agency for PRX-102 for the Treatment of Fabry Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Top-line Results from a Phase 3 Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension
Biopharmaceuticals
 HSMN NewsFeed - 31 Aug 2021
Data from Multiple Studies Show Positive Outcomes with Gala Therapeutics' RheOx(TM) System for Chronic Bronchitis
Devices
 HSMN NewsFeed - 22 Jun 2021
Valeo Pharma Announces Commercial Launch of Enerzair(R) Breezhaler(R) and Atectura(R) Breezhaler(R)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 20 May 2021
Gala Therapeutics Announces First Patients Enrolled in Pivotal Trial of RheOx(TM) System for Chronic Bronchitis
Devices
 HSMN NewsFeed - 13 May 2021
MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President of Pharmaceutical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Receive Complete Response Letter for Pegunigalsidase Alfa from FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Apr 2021
Valeo Pharma Announces Commercial Launch of Redesca(TM) and Redesca HP(TM)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 23 Feb 2021
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Positive Topline Results from BRIGHT Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa 2 mg/kg every Four Weeks for Treatment of Fabry Disease
Biopharmaceuticals
 HSMN NewsFeed - 11 Feb 2021
Protalix BioTherapeutics Enters into an Exclusive Partnership with SarcoMed USA to Develop alidornase alfa for the Treatment of Pulmonary Sarcoidosis and Related Respiratory Diseases Via Inhaled Delivery
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 27 Oct 2020
ABM Respiratory Care Raises US$10.3M in Series A Funding Round and Appoints Peter H. Soderberg as Chairman of the Board of Directors
Devices Venture Capital Personnel
 HSMN NewsFeed - 7 Oct 2020
Citius Pharmaceuticals Signs an Exclusive Worldwide Licensing Agreement with Novellus Therapeutics for Unique iMSC-Therapy for Acute Inflammatory Respiratory Conditions including COVID-19 Related Acute Respiratory Distress Syndrome (ARDS)
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 21 Sep 2020
Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners
Biopharmaceuticals
 HSMN NewsFeed - 6 Aug 2020
FDA grants inhaled use IND for RLF-100 (aviptadil) to treat patients with moderate and severe COVID-19 aiming to prevent progression to respiratory failure
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 8 Jul 2020
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 3 Jul 2020
IDELVION(R) Becomes First and Only Factor IX Therapy with 21-Day Prophylactic Dosing
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 May 2020
Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams' Role Expanded To Chairman And CEO
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 29 Apr 2020
Medical Diagnostic Laboratories, L.L.C., Launches Serological Test for Coronavirus Disease 2019 (COVID-19) Antibodies in Human Serum
Diagnostics Product Launch
 HSMN NewsFeed - 15 Apr 2020
VIDA Completes Second Close Of Round C Financing
Devices Venture Capital
 HSMN NewsFeed - 8 Apr 2020
Third Pole Therapeutics Announces Global Commercialization Agreement with Chiesi Group for Its Tankless, Portable Inhaled Nitric Oxide (iNO) Delivery System
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Jan 2020
Altavant Sciences Acquires Onspira Therapeutics, Adding a Potentially Life-Saving Treatment for Post-Lung Transplant Patients to the Altavant Pipeline
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Jan 2020
CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Dec 2019
Interscope announces new FDA Clearance of the EndoRotor(R), for use in Airway procedures including in Interventional Pulmonology
Devices Interventional Pulmonology FDA
 HSMN NewsFeed - 9 Dec 2019
HIZENTRA(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 2 Dec 2019
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Nov 2019
Protalix BioTherapeutics and Chiesi Farmaceutici Announce Successful pre-BLA Meeting with FDA for Accelerated Approval of pegunigalsidase alfa for the Treatment of Fabry Disease in the United States
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Sep 2019
New Clinical Results from RheOx(TM) System for Chronic Bronchitis to be Presented at European Respiratory Society (ERS) International Congress
Devices
 HSMN NewsFeed - 16 May 2019
Pulmatrix Announces Leadership Change
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 6 May 2019
Mallinckrodt Announces Encouraging Interim Analysis Results in Phase 4 Registry of INOmax(R) (Nitric Oxide) Gas for Inhalation for Pulmonary Hypertension in Neonates
Biopharmaceuticals
 HSMN NewsFeed - 25 Apr 2019
CSL Behring Delivers on its Continued Commitment to Alpha 1 Patients with FDA Approval of Convenient Single-Vial Dosing for ZEMAIRA(R) [Alpha1-Proteinase Inhibitor (Human)]
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 10 Apr 2019
Getinge Receives 510(k) Clearance From US FDA for Software Upgrade in Servo-u(R) and Servo-n(R) Ventilator Platform
Devices FDA
 HSMN NewsFeed - 26 Mar 2019
Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2018
Vast Therapeutics Announces Series A Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Nov 2018
Cumberland Pharmaceuticals To Acquire VIBATIV(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 11 Oct 2018
FDA Approves Stiolto(R) Respimat(R) Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 24 Sep 2018
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Aug 2018
IDELVION(R) 3500 IU Vials Now Available to Provide Convenience to Patients
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 13 Aug 2018
Cumberland Pharmaceuticals Appoints New Senior Executive
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2018
Propeller Health Raises Strategic Investment from McKesson Ventures
Devices Venture Capital
 HSMN NewsFeed - 31 May 2018
Pivot Signs Option Agreement to Acquire Licensing Rights to Patented TriVair(TM) Nasal and Pulmonary Drug Delivery System For Its "RTIC" Ready-To-Infuse-Cannabis Powder
Devices Drug Delivery Licensing
 HSMN NewsFeed - 30 May 2018
Propeller Health Raises $20 Million, Accelerating Development of Digital Medicines for Respiratory Health and Other Diseases
Devices Venture Capital
 HSMN NewsFeed - 8 May 2018
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 23 Apr 2018
Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV(R) (telavancin) at 2018 ECCMID(TM) Conference
Biopharmaceuticals
 HSMN NewsFeed - 9 Apr 2018
Cumberland Pharmaceuticals Expands into Oncology Support
Biopharmaceuticals Oncology Licensing Distribution
 HSMN NewsFeed - 3 Apr 2018
Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Mar 2018
Convexity Scientific Receives FDA Clearance For Its FLYP(TM) Nebulizer, Unveils The New Device At Medtrade Spring
Devices FDA Product Launch
 HSMN NewsFeed - 16 Mar 2018
FDA Approves Hizentra(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jan 2018
Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Dec 2017
Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion(R) System
Diagnostics FDA Product Launch
 HSMN NewsFeed - 13 Nov 2017
Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Nov 2017
Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2017
KNOW Bio Strengthens Leadership with the Addition of Four New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2017
Cepheid Expands Respiratory Disease Portfolio with Xpert Xpress Strep A
Diagnostics FDA
 HSMN NewsFeed - 25 Sep 2017
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 6 Sep 2017
Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc
Biopharmaceuticals Licensing
 HSMN NewsFeed - 31 Aug 2017
U.S. FDA Approves Chemo Group's Benznidazole to Treat Children with Chagas Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Jul 2017
HAEGARDA(R) (C1 Esterase Inhibitor Subcutaneous [Human]) Now Available in the United States for Patients with Hereditary Angioedema
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 21 Jul 2017
CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA(R) (C1 Esterase Inhibitor Subcutaneous [Human])
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jul 2017
Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals
 HSMN NewsFeed - 10 May 2017
Savara Announces Expedited U.S. Molgradex Development Strategy
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 May 2017
Ram Group Next Generation Sensor Platform Will Bring Point-of-Care Diagnostics and Wearables to Emerging Markets to Address Global Health Issues
Diagnostics Monitoring
 HSMN NewsFeed - 3 May 2017
Luminex Corporation Receives FDA Clearance for ARIES Bordetella Assay
Diagnostics FDA
 HSMN NewsFeed - 18 Apr 2017
Monitored Therapeutics, Inc. Receives FDA Clearance for First Full Home-Use Spirometer With Wireless Connection
Devices FDA
 HSMN NewsFeed - 24 Mar 2017
Reata Pharmaceuticals, Inc. Appoints David Chapman as Vice President, Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2017
New England Journal of Medicine Publishes Pivotal Phase III Data for CSL Behring's Subcutaneous C1-Esterase Inhibitor in HAE Patients
Biopharmaceuticals
 HSMN NewsFeed - 16 Feb 2017
FDA Expands Approval of SPIRIVA(R) RESPIMAT(R) (tiotropium bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Jan 2017
Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2016
Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 8 Nov 2016
Innovus Pharma Signs Exclusive License and Distribution Agreement with Elis Pharmaceuticals for Zestra(R) in Lebanon
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 7 Nov 2016
Propeller Health Receives FDA Clearance for the Propeller Platform in Association with GSK's Ellipta(R) Inhaler
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Oct 2016
Propeller Health Completes $21.5 Million Financing to Transform Respiratory Disease through Digitally-Guided Therapy
Devices Venture Capital
 HSMN NewsFeed - 5 Sep 2016
New Data: STIOLTO(R) RESPIMAT(R) (tiotropium bromide+olodaterol) Inhalation Spray Significantly Improved Exercise Capacity in People with COPD
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 11 Aug 2016
PrEP Biopharm Limited announces new CFO, Mike McGuinness, and new Head of CMC, Anna Slater
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2016
Savara Pharmaceuticals Acquires Serendex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 May 2016
Zambon Launches Xadago(R) (Safinamide) in the U.K. for Patients with Mid- to Late-Stage Parkinson’s Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 3 May 2016
Patara Pharma Appoints Biotechnology Industry Leader John Schmid to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2016
Therabron Therapeutics Appoints Eric Richman as an Independent Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2016
Eiger BioPharmaceuticals Strengthens Board of Directors with Addition of Industry Veteran Charles J. "Chuck" Bramlage
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2016
Adamis Pharmaceuticals Announces Agreement to Acquire US Compounding
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Mar 2016
Savara Pharmaceuticals Completes $20 Million Round of Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Feb 2016
Genentech Provides Update On Two Identical Phase III Studies Of Lebrikizumab In People With Severe Asthma
Biopharmaceuticals
 HSMN NewsFeed - 16 Jan 2016
Novartis receives two new FDA approvals for Cosentyx(R) (secukinumab) to treat patients with ankylosing spondylitis and psoriatic arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Jan 2016
Zambon Launches Xadago(R) (Safinamide) in Switzerland for Patients with Parkinson’s Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 3 Dec 2015
Mundipharma Establishes an Ophthalmology Business by Acquiring MSD's Portfolio of Glaucoma Products
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 28 Jul 2015
U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jul 2015
FDA approves Novartis drug Odomzo(R) (sonidegib) for locally advanced basal cell carcinoma (laBCC), a form of skin cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 May 2015
Zambon Launches Xadago(R) (safinamide) for Patients with Mid- to Late-Stage Parkinson’s Disease in Germany
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 17 Feb 2015
BioRestorative Therapies Announces the Appointment of Edward Field as President of the brtxDISC(TM) Division
Regenerative Medicine Orthopaedic Personnel
 HSMN NewsFeed - 2 Feb 2015
FDA Approves New Dosing Option for CSL Behring's Hizentra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Oct 2014
FDA Approves Boehringer Ingelheim's OFEV(R) (nintedanib) as First Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Sep 2014
NovaBiotics Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for Lynovex(R) for the Treatment of Cystic Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Aug 2014
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Aug 2014
FDA Approves Boehringer Ingelheim's Striverdi(R) Respimat(R) (olodaterol) Inhalation Spray for Maintenance Treatment of COPD
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 May 2014
Timothy Maloney appointed President of Novartis Pharmaceuticals Canada Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2014
Novartis gains FDA approval for Zykadia(TM), first therapy for patients with ALK+ NSCLC previously treated with the ALK inhibitor crizotinib
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Mar 2014
GSK and Theravance Announce Positive Results From Studies Comparing ANORO(TM) ELLIPTA(TM) With SERETIDE(R) DISKUS(R) and ADVAIR(R) DISKUS(R) in Patients With COPD
Biopharmaceuticals
 HSMN NewsFeed - 24 Jan 2014
Theravance Appoints Frank Pasqualone Senior Vice President, Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Nov 2013
Horizon Pharma and Mundipharma Sign Exclusive Agreement to Commercialize LODOTRA(R) in the Middle East and Africa
Biopharmaceuticals Distribution
 HSMN NewsFeed - 20 Sep 2013
RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Sep 2013
Civitas Therapeutics Secures $38 Million in Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 3 Sep 2013
CSL Behring Announces FDA Approval of a 10 g (50 mL) Vial Size for Hizentra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Aug 2013
Grifols and Aradigm Corporation Complete the Closing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin(R)
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 7 Aug 2013
KaloBios Appoints V. Bryan Lawlis, Jr., Ph.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2013
GW Pharmaceuticals plc Announces Sativex(R) Launch in Italy
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 22 May 2013
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personalized Medicine Personnel
 HSMN NewsFeed - 23 Apr 2013
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
Biopharmaceuticals Devices Drug Delivery Generics FDA
 HSMN NewsFeed - 27 Mar 2013
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
Biopharmaceuticals Generics Drug Delivery FDA
 HSMN NewsFeed - 21 Mar 2013
Takeda Launches New Subsidiary in Ecuador
Biopharmaceuticals
 HSMN NewsFeed - 28 Feb 2013
CSL Behring Receives FDA Approval to Expand the Indication for Corifact(R)
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 26 Feb 2013
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 17 Jan 2013
Sanovas Files for FDA Clearance of Vas Zeppelin(TM) Smart Catheter(TM)
Devices Interventional FDA
 HSMN NewsFeed - 14 Nov 2012
Biota Pharmaceuticals Announces Appointment of New Executive Officers
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2012
Pearl Therapeutics Raises $65 Million Series D to Start PT003 Phase 3
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Sep 2012
Seebri(R) Inhalation Capsules Receive MHLW Approval as Once-daily Maintenance Treatment for COPD in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Sep 2012
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Sep 2012
Civitas Therapeutics Appoints Bryan E. Stuart Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 Sep 2012
Pulmatrix Appoints Robert Clarke, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2012
Sunovion Pharmaceuticals Inc. to Acquire Elevation Pharmaceuticals, Inc.
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 13 Jul 2012
GSK and Theravance Announce Regulatory Submissions for FF/VI in the US and Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Jul 2012
GSK and Theravance Announce Positive Results From Four Pivotal Phase III Studies for Once-Daily LAMA/LABA (UMEC/VI) in COPD
Biopharmaceuticals
 HSMN NewsFeed - 27 Jun 2012
PRIMA Study Shows Treatment with Privigen(R) Improved Function in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals
 HSMN NewsFeed - 19 Jun 2012
AstraZeneca And Rigel Sign Worldwide License Agreement For A Potential New Treatment For Chronic Asthma
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 17 Apr 2012
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
Diagnostics FDA
 HSMN NewsFeed - 23 Mar 2012
GSK and Theravance Announce Completion of the Relovair(TM)* Registrational Programme and Topline Results From Relovair(TM) vs. Advair(R) Phase III Studies in COPD
Biopharmaceuticals
 HSMN NewsFeed - 15 Mar 2012
CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery
Biopharmaceuticals Surgery
 HSMN NewsFeed - 15 Feb 2012
Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty
Biopharmaceuticals
 HSMN NewsFeed - 18 Jan 2012
Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
Biopharmaceuticals
 HSMN NewsFeed - 9 Jan 2012
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies for Once-Daily Relovair(TM)* in COPD and Asthma
Biopharmaceuticals
 HSMN NewsFeed - 28 Nov 2011
CorMedix Appoints Pharmaceutical Veteran, Matthew Duffy to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Sep 2011
Takeda Completes Acquisition and Names New CEO of Nycomed
Biopharmaceuticals Personnel Mergers & Acquisitions
 HSMN NewsFeed - 15 Sep 2011
Astellas and Theravance Announce European Marketing Authorization for VIBATIV(R) for Nosocomial Pneumonia Caused by MRSA
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 31 Aug 2011
NexBio's DAS181 (Fludase(R)*) Improves Symptoms in Four Severely Immunocompromised Patients With Life-Threatening Parainfluenza Pneumonitis
Biopharmaceuticals
 HSMN NewsFeed - 15 Aug 2011
Pulmatrix Invests in Clinical Programs in COPD and Cystic Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 15 Aug 2011
Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Jun 2011
Pulmatrix Promotes Robert Clarke, PhD, to Chief Scientific Officer and Vice President of Research and Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 20 Jun 2011
Pulmatrix Launches iSPERSE(TM), A Novel Inhaled Dry Powder Drug Delivery Platform
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 2 Jun 2011
GSK and Theravance Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2011
Breathe Technologies Receives FDA Clearance for Home Use of Portable Ventilator
Devices Personnel FDA
 HSMN NewsFeed - 3 Mar 2011
InterMune Receives European Union Approval for Esbriet(R) (pirfenidone)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Feb 2011
Pearl Therapeutics Appoints Charles (Chuck) Bramlage President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 16 Feb 2011
Versartis Completes $21 Million Series B Financing
Biopharmaceuticals Endocrinology Venture Capital
 HSMN NewsFeed - 20 Jan 2011
Covidien Announces Launch of Puritan Bennett(TM) 520 Portable Ventilator in Europe
Devices
 HSMN NewsFeed - 11 Jan 2011
SUMAVEL DosePro Receives Marketing Approval in Germany and the United Kingdom
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 23 Dec 2010
Mylan's Dey Pharma Partners with Meda to Market EpiPen(R) Auto-Injector in Europe
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 14 Dec 2010
Pulmatrix Names Eva Jack as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 8 Dec 2010
Prodesse ProAdeno+ Assay Cleared for US Marketing by FDA
Diagnostics FDA
 HSMN NewsFeed - 2 Dec 2010
Regulus Therapeutics Strengthens Immunology Leadership Team with New Key Appointment
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2010
Steven Kesten, M.D., Leader in Pulmonary Medicine, Joins Uptake Medical as Vice President and Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 29 Oct 2010
Idera Pharmaceuticals Appoints Sudhir Agrawal as Chairman of Board of Directors and William S. Reardon as Lead Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2010
Pearl Therapeutics Raises $69 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Oct 2010
FDA Approves H.P. Acthar(R) Gel for the Treatment of Infantile Spasms
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Oct 2010
Privigen(R) Demonstrates Efficacy and Tolerability Among Patients With Various Immunodeficiencies, Data Show
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2010
Data Support Hizentra(R) Efficacy, Safety After Dose-Equivalent Switch in Adult and Pediatric Patients with Primary Immunodeficiency
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2010
Study Demonstrates Safety and Efficacy of Subcutaneous Vivaglobin(R) as First-Line Therapy for Primary Immunodeficiency
Biopharmaceuticals
 HSMN NewsFeed - 17 Sep 2010
Aradigm Presents Results Supporting Once-Daily Dosing With Its Inhaled Liposomal Ciprofloxacin Formulations at the 2010 European Respiratory Society (ERS) Annual Congress
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 8 Sep 2010
Tekmira Pharmaceuticals Strengthens Management Team With Addition of Paul Brennan as Senior Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2010
Advanced Life Sciences Achieves Special Protocol Assessment Agreement With FDA for Restanza in Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jul 2010
Chimerix Appoints Two New Vice Presidents to Clinical Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2010
FDA Approves Merck's DULERA(R) (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Jun 2010
Bohai Pharmaceuticals Expands Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2010
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 May 2010
Abbott Accelerates Emerging Markets Pharmaceutical Leadership With Zydus Cadila Collaboration; Separately Creates Stand-Alone Established Products Division
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Apr 2010
Idera Pharmaceuticals Announces Management Appointments and Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jan 2010
Phadia Brings the First and Only Point of Care In Vitro Specific IgE Allergy Test into the Physician's Office with Final FDA Clearance of the ImmunoCAP(R) Rapid System
Diagnostics FDA
 HSMN NewsFeed - 26 Jan 2010
Idera Pharmaceuticals Announces the Appointment of Malcolm MacCoss, Ph.D., to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jan 2010
Elevation Pharmaceuticals Raises $30 Million in Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Dec 2009
MicroDose Therapeutx Acquires Epix Pharmaceuticals Portfolio of Compounds for Treatment of Chronic Constipation and Irritable Bowel Syndrome with Constipation (IBS-C)
Biopharmaceuticals Gastroenterology Acquisitions
 HSMN NewsFeed - 27 Nov 2009
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Nov 2009
STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Nov 2009
Oxagen Limited Raises £16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Nov 2009
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Nov 2009
Altair Therapeutics Secures $17 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Nov 2009
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Biopharmaceuticals
 HSMN NewsFeed - 5 Oct 2009
Baxter Announces the Commercial Launch of HYLENEX at ACEP for Use in Pediatric Rehydration
Biopharmaceuticals
 HSMN NewsFeed - 1 Oct 2009
Astellas and Theravance Announce Approval of VIBATIV(TM) (telavancin) in Canada for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Jul 2009
Intellikine Completes $51 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Jun 2009
Bionovo Appoints Dr. Klaus Kohl as Chief Technical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2009
Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2009
Altair Therapeutics Appoints Dr. Joel Martin President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2009
GE Healthcare Announces Data from Phase III Study of AdreView in Heart Failure Patients
Biopharmaceuticals Cardiology Radiology
 HSMN NewsFeed - 24 Mar 2009
FDA Approves New Indication for Wyeth's TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Mar 2009
Pearl Therapeutics Appoints Perry Karsen as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jan 2009
Targin(R) (Oral Oxycodone/Naloxone Prolonged-Release Tablet) now Launching Across Europe to Control Severe Chronic Pain With Significantly Reduced Risk of Opioid-Induced Constipation
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2009
TOPIGEN Pharmaceuticals Reports Phase 2 Results of TPI ASM8 in Asthma Patients
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2009
Dey L.P. Settles State of Mississippi Pricing Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 6 Jan 2009
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Nov 2008
MedImmune Announces Zook as President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2008
Antares Pharma Appoints Paul K. Wotton, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Oct 2008
deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 1 Oct 2008
Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
Biopharmaceuticals
 HSMN NewsFeed - 1 Oct 2008
Advanced Life Sciences Announces NDA Submission for Cethromycin in Community Acquired Pneumonia
Biopharmaceuticals
 HSMN NewsFeed - 23 Sep 2008
Oriel Therapeutics Appoints Richard Fuller as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2008
MAP Pharmaceuticals Appoints Alan H. Cohen, M.D., as Vice President, Clinical Development and Medical Affairs, Pulmonary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Sep 2008
Akorn-Strides, LLC Announces FDA Approvals for Dexamethasone Sodium Phosphate Injection USP, 4 mg (base)/mL and Dexamethasone Sodium Phosphate Injection USP, 10 mg (base)/mL
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 Aug 2008
TOPIGEN Pharmaceuticals Appoints Mark Parry-Billings, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Aug 2008
ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Aug 2008
Pharmacopeia Announces Further Reductions to Workforce
Biopharmaceuticals
 HSMN NewsFeed - 2 Aug 2008
Inhaler Devices are Still a Major Hurdle in Asthma and COPD Treatment
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 22 Jul 2008
Response Biomedical Receives US FDA Clearance for RAMP(R) NT-proBNP Test for Diagnosis of Heart Failure
Diagnostics Cardiology FDA
 HSMN NewsFeed - 14 Jul 2008
Immunomedics Announces Worldwide License and Collaboration Agreement With Nycomed for Veltuzumab for Non-Cancer Indications
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 7 Jul 2008
Antares Pharma Appoints Paul Wotton, Ph.D. as President and Chief Operating Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 2 Jul 2008
Pearl Therapeutics Closes $18 Million Financing Round Led By Committed Investors
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Jul 2008
nSpire Health Awarded Three-Year Agreement with Premier Group Purchasing Organization
Devices Group Purchasing
 HSMN NewsFeed - 10 Jun 2008
Otsuka and UCB agreed to co-develop and co-promote Keppra(R) and Cimzia(R) in Japan
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2008
US FDA grants pediatric exclusivity for UCB's Keppra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jun 2008
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 May 2008
Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 May 2008
Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 12 May 2008
Pipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 May 2008
New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 6 May 2008
MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2008
Aradigm Announces Data Showing No Occurrence of Primary Lung Cancer in Patients Treated with AERx(R) Insulin Diabetes Management System (iDMS)
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 25 Apr 2008
Neupro(R) recommended for approval in Europe for Restless Legs Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Apr 2008
Cimzia(R) Approved in the US for the Treatment of Moderate to Severe Crohn's Disease
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 17 Apr 2008
Accentia Announces that After Reviewing Unblinded Results, Independent DMC Recommends Presenting Data on BiovaxID(R) to FDA and Worldwide Regulatory Agencies in Order to Seek Marketing Approvals for Follicular Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Apr 2008
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2008
Collegium Pharmaceutical Announces FDA Filing for AllerNase(TM), a Nasal Inhaled Steroid for the Treatment of Allergic Rhinitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Mar 2008
Discovery Labs Adds Two Executives to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2008
Breathe Technologies, Inc. Closes on $15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
Devices Venture Capital
 HSMN NewsFeed - 24 Mar 2008
Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage
Biopharmaceuticals
 HSMN NewsFeed - 20 Mar 2008
CHMP Upholds Negative Opinion for the EU Application for Cimzia(R) in the Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 20 Mar 2008
UCB advises US-physicians to down-titrate patients on Neupro(R) in view of out-of-stock situation in the US
Biopharmaceuticals Neurology Product Recall
 HSMN NewsFeed - 10 Mar 2008
Auriga Laboratories Announces FDA Approval of Liquadd(TM) (Dextroamphetamine Sulfate) Oral Solution for the Treatment of ADHD and Upcoming Product Launch
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Mar 2008
FDA Accepts for Review Theravance's Complete Response to Approvable Letter for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Mar 2008
TOPIGEN Pharmaceuticals Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2008
UCB: Early Data on Cimzia(R) from the WELCOME Study Show Efficacy in Infliximab-Refractory Crohn's Disease Patients
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 3 Mar 2008
Changes in UCB's Executive Committee
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2008
Pharmacopeia Announces Management Team Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2008
FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Feb 2008
Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Feb 2008
FDA Agrees to Review Cimzia(R) File for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jan 2008
Pipex Pharmaceuticals Provides Update on COPREXA (Oral Tetrathiomolybdate) New Drug Application
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Jan 2008
Frank R. Greico Named CEO of Auriga Laboratories
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jan 2008
Teva Specialty Pharmaceuticals and UCB Announce U.S. Respiratory Collaboration Agreement
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2008
Nastech Appoints Bruce R. York as Interim Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2008
Luminex Corporation Receives U.S. Food and Drug Administration Clearance for xTAG(TM) Respiratory Viral Panel
Diagnostics FDA
 HSMN NewsFeed - 28 Dec 2007
Inflazyme Pharmaceuticals Announces Departure of Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Dec 2007
Theravance Receives Notice of Possible Telavancin Review by FDA Advisory Committee
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Dec 2007
New Drug Application for Tolvaptan, Otsuka's Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Dec 2007
Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share
Devices Mergers & Acquisitions
 HSMN NewsFeed - 20 Dec 2007
Nastech Announces Promotion of Gordon Brandt, M.D. to President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Dec 2007
Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2007
Forward Ventures Joins Series A Syndicate for Newly Formed Altair Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Restless Legs Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Dec 2007
New Phase III Trial Shows Positive Outcome of lacosamide in Patients with Diabetic Neuropathic Pain
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2007
Theravance Announces Positive Topline Results In Phase 3 Telavancin Hospital-Acquired Pneumonia Program
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2007
Neupro(R) Filed in Europe for the Treatment of Restless Legs Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Dec 2007
UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Dec 2007
UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Nov 2007
UCB Announces FDA Filing for lacosamide in the Treatment of Diabetic Neuropathic Pain
Biopharmaceuticals
 HSMN NewsFeed - 29 Nov 2007
UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Nov 2007
Meridian Bioscience Receives FDA Clearance for Two New Rapid Tests for the Detection of Influenza and Respiratory Syncytial Virus
Diagnostics FDA
 HSMN NewsFeed - 26 Nov 2007
Orexo Announces New Executive Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Nov 2007
Orexo Completes the Acquisition of Biolipox, Appoints New CEO and Publishes a Prospectus
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 16 Nov 2007
UCB to Appeal European Negative Opinion on CIMZIA(R) for the Treatment of Patients with Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 13 Nov 2007
Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs
Biopharmaceuticals
 HSMN NewsFeed - 12 Nov 2007
Orexo Acquires Biolipox
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Oct 2007
Biotech Veteran Joins AerovectRx as CEO
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 29 Oct 2007
N30 Pharma Announces License Agreement With NitroMed, Inc.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 26 Oct 2007
Orexo to Acquire Biolipox - Update
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Oct 2007
UCB Announces Initiation of Phase III Clinical Program for RikeltaTM (brivaracetam) as Adjunctive Treatment in Partial-Onset Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 25 Oct 2007
Aradigm Corporation Reports Initial Human Data on a Novel Approach to Treatment of Tobacco Smoking Addiction Using its AERx Essence(R) Nicotine Inhaler
Devices Drug Delivery
 HSMN NewsFeed - 24 Oct 2007
Two Clinical Trials for Nebulized Formoterol Fumarate on Long-Term and Cardiovascular Safety in Treating COPD
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2007
Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2007
FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
Biopharmaceuticals
 HSMN NewsFeed - 22 Oct 2007
Study Using PARI Nebulizer Finds COPD Therapy of Nebulizer and Inhaler Combo More Effective than Inhaler Alone
Devices Drug Delivery
 HSMN NewsFeed - 22 Oct 2007
Theravance Receives FDA Approvable Letter for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Oct 2007
TransMolecular, Inc. Names Morphotek Executive Nicholas C. Nicolaides, Ph.D., Chairman of the Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Oct 2007
Biovest Announces Strategy for Seeking Early Approval of Its Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Oct 2007
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Oct 2007
Accentia Announces Investigational New Drug Application for Revimmune Usage in a Pivotal Phase 3 Study of Refractory Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Oct 2007
Accentia Biopharmaceuticals Announces Completion of Enrollment in Fast-Tracked Pivotal Phase 3 Clinical Trial of SinuNase for Chronic Sinusitis
Biopharmaceuticals
 HSMN NewsFeed - 8 Oct 2007
Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 8 Oct 2007
Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinson's Disease
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 8 Oct 2007
Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
Biopharmaceuticals
 HSMN NewsFeed - 4 Oct 2007
Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery
Biopharmaceuticals Personnel Drug Delivery
 HSMN NewsFeed - 27 Sep 2007
Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
Biopharmaceuticals
 HSMN NewsFeed - 26 Sep 2007
New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 25 Sep 2007
Critical Therapeutics Highlights Near-Term Milestones to Drive Commercial Success and Clinical Development
Biopharmaceuticals
 HSMN NewsFeed - 24 Sep 2007
Inflazyme Pharmaceuticals Signs Asset Sale Agreement With Biolipox for a Potential Value of up to $11 Million, Plus a Potential Royalty Payment
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Sep 2007
Pipex Pharmaceuticals Plans November NDA Filing for COPREXA Based on Pre-NDA Meetings With FDA
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Sep 2007
Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Sep 2007
Theravance Retains Full Ownership of Gastrointestinal Motility Dysfunction Program and TD-1792 Antibiotic
Biopharmaceuticals Gastroenterology Licensing
 HSMN NewsFeed - 6 Sep 2007
Aradigm and CyDex Sign Development Collaboration Agreement
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 28 Aug 2007
Auriga Laboratories Appoints Frank R. Greico as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Aug 2007
UCB Announces Submission of Lacosamide Marketing Application for Diabetic Neuropathic Pain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Aug 2007
TOPIGEN Secures C$26M (US$25M) in Series C Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Aug 2007
Accentia Biopharmaceuticals Updates Interim Analysis of Blinded Clinical Results in the Fast-Tracked Pivotal Phase 3 Trial of SinuNase for the Treatment of Refractory Chronic Sinusitis
Biopharmaceuticals
 HSMN NewsFeed - 6 Aug 2007
Bayer HealthCare and Nektar Therapeutics Launch Global Development and Commercialization Agreement to Fight Gram-Negative Pneumonias
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 31 Jul 2007
Theravance Announces Appointment of Leonard M. Blum as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2007
Accentia Biopharmaceuticals Files Pre-Investigational New Drug (IND) Application with FDA for Pivotal Phase 3 Clinical Trial of Revimmune for Refractory Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Jul 2007
A.T.S. Pharmaceuticals, A division of Auriga Laboratories Launches Xyralid(TM) LP Lotion
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 20 Jul 2007
Auriga Laboratories Appoints Lisa Tripodi as Vice President of Trade Relations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jul 2007
Pivotal CIMZIA(TM) Data in Crohn's Disease Published in New England Journal of Medicine
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 16 Jul 2007
UCB Announces the U.S. Launch of Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Jul 2007
SCHWARZ PHARMA and UCB, Inc. Announce U.S. Launch of Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 9 Jul 2007
Roche and Alnylam Form Major Alliance on RNAi Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 8 Jul 2007
Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Biopharmaceuticals
 HSMN NewsFeed - 5 Jul 2007
Auriga Laboratories Appoints Rick Coulon Vice President of Consumer Brands
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2007
Aradigm Corporation Names Norman Halleen as Interim Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 2 Jul 2007
Tamiflu(R) 30 mg and 45 mg Capsules Approved by U.S. Food and Drug Administration
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jun 2007
Bionovo Appoints Tom Chesterman as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jun 2007
Auriga Laboratories Appoints Leonhard Dreimann and Thomas Heck to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jun 2007
UCB and Biogen Idec's Oral VLA-4 Antagonist Enters Phase II Development for Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Jun 2007
Auriga Laboratories Announces the Formation of A.T.S. Pharmaceuticals, a Specialty Division dedicated to Dermatology and Gastroenterology
Biopharmaceuticals Dermatology Gastroenterology
 HSMN NewsFeed - 18 Jun 2007
Sepracor Issues Statement Regarding CMS Medicare Part B Reimbursement Change for XOPENEX(R) Inhalation Solution
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 14 Jun 2007
Shire's ELAPRASE(TM) (idursulfase) Approved by Health Canada for Treatment of Hunter Syndrome
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Jun 2007
Response Biomedical Receives Approval to Market NT-proBNP Congestive Heart Failure Marker Test in Canada
Diagnostics Cardiology Regulatory
 HSMN NewsFeed - 5 Jun 2007
Biovest to File for Accelerated Conditional Approval of BiovaxID
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Jun 2007
Aradigm Names D. Jeffery Grimes as General Counsel and Corporate Secretary
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 Jun 2007
Pharmaxis' Aridol Gains European Approval
Diagnostics Regulatory
 HSMN NewsFeed - 30 May 2007
Theravance Announces Acceptance of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 May 2007
FDA Approves XYZAL(R) (Levocetirizine Dihydrochloride) Tablets for the Relief of Seasonal and Year Round Allergies, and Chronic Hives
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 May 2007
UCB Presents Long-Term CIMZIA(TM) Data in Crohn's Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 21 May 2007
Clinical Trial Data for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2007
Sepracor Announces Management Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2007
Accentia Biopharmaceuticals Makes Milestone Payment Based on Fast Tracked Pivotal Phase 3 Study with SinuNase for the Treatment of Chronic Sinusitis
Biopharmaceuticals
 HSMN NewsFeed - 11 May 2007
FDA Approves Dey, L.P.'s Perforomist(TM) (Formoterol Fumarate) Inhalation Solution for Maintenance Treatment of COPD
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 May 2007
Auriga Laboratories Appoints Elliot M. Maza To Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 May 2007
Physicians at Siteman Cancer Center Treat Inoperable Lung Cancer With Image-Guided Radiosurgery Using Trilogy(R) Technology From Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 1 May 2007
Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Apr 2007
UCB Announces Positive Top-Line Phase III Results for Keppra(R) as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Apr 2007
Genaera Corporation Names New Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2007
TOPIGEN Expands Executive Team With Senior Business Development and Pharmaceutical Development Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2007
Merck and Schering-Plough to Develop Another New Cholesterol Lowering Medicine
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Mar 2007
EVEREST Data on Short- and Long-Term Use of Otsuka's Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACC's Late Breaking Clinical Trials
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 Mar 2007
UCB Provides Update on CIMZIA(TM) for Crohn's Disease and Rheumatoid Arthritis in the US
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 20 Mar 2007
Keppra(R) Approved for US Epilepsy Patients with One of the Most Debilitating Seizure Types
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Mar 2007
Auriga Laboratories Sales Force Doubles Again to 200 Associates since January
Biopharmaceuticals
 HSMN NewsFeed - 16 Mar 2007
Diffusion Pharmaceuticals Initiates Human Trial of Lead Drug Candidate, Trans Sodium Crocetinate (TSC)
Biopharmaceuticals
 HSMN NewsFeed - 14 Mar 2007
Critical Therapeutics and DEY, L.P. Enter into Co-Promotion Agreement for Respiratory Care Products
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2007
PARI's Hydrate Receives FDA 510k Clearance
Devices FDA
 HSMN NewsFeed - 12 Mar 2007
New European Approval for Xyrem(R) Provides Significant Advance in the Treatment of Narcolepsy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Mar 2007
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 9 Mar 2007
Roche Files Supplemental New Drug Application with U.S. Food & Drug Administration for Tamiflu(R) 30 mg and 45 mg Capsules
Biopharmaceuticals
 HSMN NewsFeed - 8 Mar 2007
HemoSense Signs Agreement for INRatio Distribution in Canada
Diagnostics Distribution
 HSMN NewsFeed - 27 Feb 2007
Auriga Settles Lawsuit to Reduce Royalties Payable on Levall Product Line by Approximately $10 Million
Biopharmaceuticals Litigation
 HSMN NewsFeed - 20 Feb 2007
Theravance Announces FDA Acceptance of Telavancin NDA
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2007
Trevor K. Pokorney Joins Auriga Laboratories Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Feb 2007
EMEA Grants Orphan Drug Designation to BioCryst's Fodosine(TM) for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Jan 2007
Nycomed Officially Launched as Combined Group
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Jan 2007
More European Patients With Epilepsy to Benefit From Keppra(R)
Biopharmaceuticals Regulatory Neurology
 HSMN NewsFeed - 16 Jan 2007
BioCryst Initiates Pivotal Fodosine(TM) Phase IIb Clinical Trial in Patients With Relapsed/Refractory T-Lymphoblastic Leukemia/Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Jan 2007
Aradigm Receives FDA Orphan Drug Designation for Liposomal Ciprofloxacin for Bronchiectasis
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Jan 2007
Auriga Laboratories Appoints Jae Yu As Vice President of Finance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2007
Genaera Corporation Terminates EVIZON(TM) Clinical Program and Restructures
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 3 Jan 2007
Auriga Laboratories Appoints Richard K. Sampson as National Sales Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Dec 2006
Sirna Therapeutics Shareholders Approve Acquisition by Merck & Co.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Dec 2006
UCB Announces Positive Results From Two New Phase III Studies in Rheumatoid Arthritis and Provides Update on the Status of US Approval for CIMZIATM in the Treatment of Crohn's Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Dec 2006
Accentia Biopharmaceuticals in Discussions with Pharmaceutical Companies on SinuNase Partnership
Biopharmaceuticals
 HSMN NewsFeed - 18 Dec 2006
Aerovance Adds Accomplished Product Commercialization Executive to Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2006
Abbott Completes Acquisition of Kos Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Dec 2006
Critical Therapeutics Announces NIH-Sponsored Study to Investigate the Efficacy Of ZYFLO(R) In Patients with Acute Exacerbations Of COPD
Biopharmaceuticals
 HSMN NewsFeed - 14 Dec 2006
Merck & Co. and Sirna Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period for the Proposed Acquisition of Sirna by Merck
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Dec 2006
Response Biomedical Files for US FDA 510k Market Clearance of RAMP NT-proBNP Test for the Diagnosis of Congestive Heart Failure
Diagnostics Cardiology FDA
 HSMN NewsFeed - 14 Dec 2006
Auriga Laboratories Increases Pharmaceutical Sales Representatives
Biopharmaceuticals
 HSMN NewsFeed - 4 Dec 2006
Nastech Pharmaceutical Company Inc. Provides Update on Parathyroid Hormone (PTH1-34) Nasal Spray for Treatment of Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 27 Nov 2006
Biota and Boehringer Ingelheim Complete US$102 Million License for HCV Program
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Nov 2006
FDA Allows Resumption of Lupus Trials with Epratuzumab
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2006
Auriga Laboratories Appoints Charles R. Bearchell as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2006
Accentia Biopharmaceuticals Commences Fast-Tracked Phase 3 Clinical Trial of SinuNase for the Treatment of Chronic Sinusitis
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2006
Abbott to Expand Presence in Lipid Management Market With Acquisition of Kos Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Oct 2006
Merck & Co., Inc. to Acquire Sirna Therapeutics, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 26 Oct 2006
Auriga Laboratories Enters Into Co-Marketing Agreement With Pharmelle LLC for Sale of Company's Aquoral Product
Biopharmaceuticals Urology
 HSMN NewsFeed - 23 Oct 2006
New Data Show CIMZIA(TM) (certolizumab pegol) May Improve Productivity in Work and with Daily Activities for People with Crohn's Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 23 Oct 2006
New Analysis Shows CIMZIA(TM) (Certolizumab Pegol) Maintained Remission and Response in Recent Onset Crohn's Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 23 Oct 2006
New Efficacy Data Show CIMZIA(TM) (Certolizumab Pegol) Maintained Response and Remission in Crohn's Patients Previously Treated With Infliximab
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 20 Oct 2006
Auriga Expands Brand Portfolio with Exclusive Licensing of Five Prescription Dermatology Products from River's Edge Pharmaceuticals
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 19 Oct 2006
New Landmark Study Shows the Use of a BiovaxID Formulation Improves Disease Free survival in 80% of Patients Whose Cancer has Relapsed after Chemotherapy Administered With or Without Rituxan
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Oct 2006
Genaera Presents New EVIZON(TM) Safety Data at the Angiogenesis Foundation 4th Annual International Conference
Biopharmacetuicals Ophthalmology
 HSMN NewsFeed - 10 Oct 2006
Ingen Technologies Begins Production of OxyView(TM)
Devices
 HSMN NewsFeed - 10 Oct 2006
Theravance Announces Additional Results From Successful Phase 3 Telavancin Complicated Skin and Skin Structure Program
Biopharmaceuticals
 HSMN NewsFeed - 5 Oct 2006
GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New Option for Fighting the Flu
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Oct 2006
Auriga Executes Agreement Naming River's Edge Pharmaceuticals as Authorized Generic Distributor of Extendryl and Levall
Biopharmaceuticals Distribution Generics
 HSMN NewsFeed - 3 Oct 2006
UCB and Jazz Pharmaceuticals Announce Expansion of Xyrem(R) License Agreement to Include Fibromyalgia Syndrome
Biopharmaceuticals Licensing
 HSMN NewsFeed - 3 Oct 2006
ALTANA Pharma Announces Strategic Realignment of the U.S. Business
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2006
New Data Reinforce Efficacy of TRIZIVIR(R) Alone in Treatment-Naive HIV Patients with Low Viral Load
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 25 Sep 2006
sanofi-aventis and UCB Sign a Co-Promotion Agreement for Xyzal(R) in the United States
Biopharmaceuticals
 HSMN NewsFeed - 25 Sep 2006
UCB and sanofi-aventis sign a co-promotion agreement for Xyzal(R) in the United States
Biopharmaceuticals
 HSMN NewsFeed - 21 Sep 2006
Kos Announces Positive Overall Results for Two Phase III Trials of Icatibant for the Treatment of Hereditary Angioedema
Biopharmaceuticals
 HSMN NewsFeed - 21 Sep 2006
ALTANA AG: Sale of Pharmaceuticals Business to Nycomed
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Sep 2006
UCB Appoints Fabrice Egros, Ph.D., MBA, President of U.S. Subsidiary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2006
Auriga Laboratories Announces Acquisition of Aquoral(TM) Product Line
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Sep 2006
Statement from Dey, L.P. Regarding Pricing Litigation by the U.S. Department of Justice
Biopharmaceuticals Litigation
 HSMN NewsFeed - 6 Sep 2006
Dynavax Establishes Collaboration for TLR-9 Agonists for Asthma and COPD With AstraZeneca
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Sep 2006
SkyePharma and Mundipharma Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Sep 2006
Former Chiron Exec Joins APT Pharmaceuticals as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2006
Response Biomedical Completes US Distribution Network For RAMP Cardiovascular Products
Diagnostics Cardiology Distribution
 HSMN NewsFeed - 18 Jul 2006
Theravance and Astellas Add Japan to Collaboration on Telavancin, Investigational Antibiotic for Serious Infections
Biopharmaceuticals
 HSMN NewsFeed - 13 Jul 2006
Nastech Pharmaceutical Company Receives FDA Communication Concerning Calcitonin-Salmon Nasal Spray
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jul 2006
Kos Submits Supplemental New Drug Application To FDA For New Niaspan(R) CF Range of Products
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 12 Jul 2006
VIASYS Healthcare Inc. Acquires Tiara Medical Systems, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 3 Jul 2006
A Key Regulatory Milestone for Keppra
Biopharmaceuticals Regulatory Neurology
 HSMN NewsFeed - 27 Jun 2006
Auriga Laboratories Promotes Senior Vice President of Sales and Marketing Andrew Shales to Position of Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2006
UCB Sells to Adams Respiratory Therapeutics OTC Delsym(R) 12-Hour Cough Suppressant Liquids
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 May 2006
Association Between Molecular Remission and Disease-Free Survival in Non-Hodgkins Lymphoma at Over Nine Years Follow-Up To Be Presented
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 May 2006
UCB Completes Mutual Recognition Procedure for Equasym(TM) XL
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 May 2006
New CIMZIA (TM) Data from PRECiSE Program Reinforce Robust Efficacy in Once-Monthly Treatment of Crohn's Disease and Consistent Tolerability Profile
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 16 May 2006
FDA Gives Permission to Use Very Sensitive Molecular Evidence of Cancer in BiovaxID Pivotal Phase 3 Clinical Trial
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 May 2006
Theravance Announces Enrollment of Last Patient in Phase 3 Complicated Skin and Skin Structure Infections Clinical Program With Investigational Antibiotic, Telavancin
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2006
European Commission Approves Keppra(R) for Use as Adjunctive Therapy in the Treatment of Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 15 May 2006
Response Biomedical and Shionogi Finalize Commercialization Agreement For RAMP Cardiovascular Testing in Japan
Diagnostics Cardiology
 HSMN NewsFeed - 11 May 2006
FDA Grants Accentia Biopharmaceuticals, Inc.'s Majority-Owned Subsidiary Fast Track Status for BiovaxID(TM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 May 2006
Biovest's AutovaxID(TM) Cleared for Commercial Sale
Biopharmaceuticals Devices FDA
 HSMN NewsFeed - 10 May 2006
UCB and Immunomedics announce worldwide development collaboration and license agreement for Epratuzumab
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 May 2006
Immunomedics and UCB Announce Worldwide Development Collaboration and License Agreement for Epratuzumab
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 May 2006
Accentia Biopharmaceuticals Receives FDA Approval for Three Unique Dosage Combination Pain Product ANDAs
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 May 2006
Kos and SkyePharma Sign Exclusive License Agreement for the Marketing and Distribution of Flutiform(TM) in the United States
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 4 May 2006
Aerovance Secures $60 Million in Financing
Biopharmaceuticals Venture Capital
Return to NewsFeed  

 Additional items found! 219

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 219 additional stories matching:
respiratory disease
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!